MAKE FASTER DRUG DEVELOPMENT DECISIONS WITH EVIDENCE YOU CAN TRUST.
Give your team AI-powered access to millions of compounds, reactions, protein structures, clinical trials, patents, and more through the Valyu API.
Valyu helps biotech and pharma teams move faster.
From target discovery to regulatory approval, Valyu delivers the evidence your team needs to move with confidence.
Improved efficiency, enchanced workflow.
Improve your workflow with better search.
Surface evidence faster
PubChem has 115M compounds. AlphaFold has 200M protein structures. Open Reaction Database and USPTO contain 5M+ reactions. Your AI can search across all of them, and more, using Valyu.
Protect your pipeline
Search USPTO patent filings alongside reaction data so your team can assess freedom to operate early and avoid costly surprises late.
Anticipate regulatory shifts
Track FDA labels, approval decisions, and guidance updates so your team can anticipate requirements, not react to them.
Trust every answer
Every result links back to its source. Whether it's a reaction, a trial, or a protein structure, your team can verify it, cite it, and move forward with confidence.
Empowering AI-driven teams across the discovery process.
Make confident decisions at every stage.
Whether it's discovery, development, or regulatory review, Valyu gives pharma and biotech teams the evidence they need to move faster.
Discover moreReady to give yourAI the data it needs?
Schedule a demo to see how Valyu powers drug development workflows at scale.